Tuberculosis associated with therapy against tumor necrosis factor α
نویسندگان
چکیده
منابع مشابه
Association of VNTR polymorphism of tumor necrosis factor receptor 2 (TNFRSF1B) with pulmonary tuberculosis
This study was designed to find out the impact of the variable number of tandem repeats (VNTR) of the tumor necrosis factor receptor 2 (TNFRSF1B) on pulmonary tuberculosis (PTB) risk in an Iranian population. This case-control study was done on 159 PTB patients and 158 healthy subjects. Bi-allelic TNFRSF1B VNTR was genotyped by polymerase chain reaction. Logistic regression analysis revealed no...
متن کاملBrain Abscess Caused by Capnocytophaga Species Associated with Anti-Tumor Necrosis Factor-α Therapy
Capnocytophaga spp. are a rare cause of fulminant sepsis in individuals who have been bitten or scratched by a dog. Immunocompromised individuals are at high risk of Capnocytophaga spp. infections [1]. Anti-tumor necrosis factor-α (anti-TNF-α) drugs are a class of drugs that are used worldwide to treat patients with rheumatoid arthritis (RA) and selected other autoimmune inflammatory diseases. ...
متن کاملIncidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy
PURPOSE Anti-tumor necrosis factor-alpha (TNF-α) medications represent a major advancement in the management of chronic inflammatory diseases. However, these agents are associated with increased risks of tuberculosis (TB) and other serious infections. The aim of this study was to evaluate the incidences of such disease among tertiary hospitals in Korea. MATERIALS AND METHODS We retrospectivel...
متن کاملUnusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis complex mycobacteria. Extrapulmonary tuberculosis usually develops more than two years after infection or many years later. Factors favoring onset of the disease are malnutrition, older age, renal failure, diabetes, cancer, immunosuppression and biological treatment, e.g. tumor necrosis factor α (TNF-α) inhibitors. The p...
متن کاملNontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
Patients receiving anti-tumor necrosis factor-alpha (anti-TNF-alpha) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous mycobacteria (NTM) in this setting. We reviewed the US Food and Drug Administration MedWatch database for reports of NTM disease in patients receiving anti-TNF-alpha therapy. Of 239 report...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arthritis & Rheumatism
سال: 2005
ISSN: 0004-3591,1529-0131
DOI: 10.1002/art.21382